- Home
- MIRM vs BTMWW Comparison
MIRM vs BTMWW Comparison
Compare MIRM & BTMWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRM
- BTMWW
- Stock Information
- Founded
- MIRM 2018
- BTMWW N/A
- Country
- MIRM United States
- BTMWW United States
- Employees
- MIRM N/A
- BTMWW 126
- Industry
- MIRM Biotechnology: Pharmaceutical Preparations
- BTMWW Finance: Consumer Services
- Sector
- MIRM Health Care
- BTMWW Finance
- Exchange
- MIRM Nasdaq
- BTMWW Nasdaq
- Market Cap
- MIRM 1.9B
- BTMWW N/A
- IPO Year
- MIRM 2019
- BTMWW 2022
- Fundamental
- Price
- MIRM $39.10
- BTMWW $0.06
- Analyst Decision
- MIRM Strong Buy
- BTMWW
- Analyst Count
- MIRM 11
- BTMWW 0
- Target Price
- MIRM $58.55
- BTMWW N/A
- AVG Volume (30 Days)
- MIRM 476.2K
- BTMWW N/A
- Earning Date
- MIRM 05-07-2025
- BTMWW N/A
- Dividend Yield
- MIRM N/A
- BTMWW N/A
- EPS Growth
- MIRM N/A
- BTMWW N/A
- EPS
- MIRM N/A
- BTMWW N/A
- Revenue
- MIRM $336,888,000.00
- BTMWW N/A
- Revenue This Year
- MIRM $29.51
- BTMWW N/A
- Revenue Next Year
- MIRM $20.27
- BTMWW N/A
- P/E Ratio
- MIRM N/A
- BTMWW N/A
- Revenue Growth
- MIRM 80.76
- BTMWW N/A
- 52 Week Low
- MIRM $23.14
- BTMWW N/A
- 52 Week High
- MIRM $54.23
- BTMWW N/A
- Technical
- Relative Strength Index (RSI)
- MIRM 34.64
- BTMWW N/A
- Support Level
- MIRM $37.83
- BTMWW N/A
- Resistance Level
- MIRM $40.32
- BTMWW N/A
- Average True Range (ATR)
- MIRM 2.47
- BTMWW 0.00
- MACD
- MIRM -0.33
- BTMWW 0.00
- Stochastic Oscillator
- MIRM 25.14
- BTMWW 0.00
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
About BTMWW Bitcoin Depot Inc. Warrant
Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.